HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xueying Qiao Selected Research

Adenocarcinoma

3/2021Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.
1/2021Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction.
1/2018Comparison of preoperative concurrent chemoradiotherapy with chemotherapy alone in patients with locally advanced siewert II and III adenocarcinoma of the esophagogastric junction.
6/2015Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction.
2/2007Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xueying Qiao Research Topics

Disease

8Esophageal Squamous Cell Carcinoma
06/2021 - 02/2007
5Adenocarcinoma
03/2021 - 02/2007
4Neoplasms (Cancer)
06/2021 - 06/2015
3Esophageal Neoplasms (Esophageal Cancer)
06/2021 - 01/2020
2Infections
05/2010 - 03/2010
1Extranodal NK-T-Cell Lymphoma
12/2021
1Lymphoma (Lymphomas)
12/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2021
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2020
1Lymphatic Metastasis
01/2020
1High Pressure Neurological Syndrome (High Pressure Nervous Syndrome)
04/2019
1Neutropenia
06/2015
1Leukopenia
06/2015
1Thrombocytopenia (Thrombopenia)
06/2015
1Anemia
06/2015
1Carcinoma (Carcinomatosis)
02/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2003
1Cardiovascular Diseases (Cardiovascular Disease)
07/2003

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
05/2010 - 03/2010
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2021
1Capecitabine (Xeloda)FDA Link
03/2021
1PolyethyleneimineIBA
04/2019
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
04/2019
1carbopol 940 (sodium polyacrylate)IBA
04/2019
1ferroceneIBA
04/2019
1XELOXIBA
06/2015
1GlutaredoxinsIBA
03/2010

Therapy/Procedure

9Radiotherapy
06/2021 - 07/2003
7Chemoradiotherapy
10/2021 - 06/2015
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2021 - 01/2020
2Conformal Radiotherapy
05/2021 - 01/2020
2Neoadjuvant Therapy
03/2021 - 06/2015
2Drug Therapy (Chemotherapy)
01/2020 - 01/2018
2Esophagectomy
01/2016 - 08/2015
1Drug Tapering
12/2021
1Cranial Irradiation
10/2021
1Nanospheres
04/2019
1Therapeutics
01/2018
1Contraindications
07/2003